HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients

Aim: Colorectal cancer (CRC) is one of the leading cancers in the world. Even though its mortality and pathophysiology are well documented in the US and the European countries, it is seldom studied in North African population. Recent studies have shown link of HER2 overexpression in oesophageal and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eman A. Abdul Razzaq, Thenmozhi Venkatachalam, Khuloud Bajbouj, Mohamed Rahmani, Amena Mahdami, Surendra Rawat, Naziha Mansuri, Hussein Alhashemi, Rifat Akram Hamoudi, Riyad Bendardaf
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2021
Materias:	her2 crc ihc Medicine R
Acceso en línea:	https://doaj.org/article/5ca28717abc94432969cecb6f0fff3cf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5ca28717abc94432969cecb6f0fff3cf
record_format	dspace
spelling	oai:doaj.org-article:5ca28717abc94432969cecb6f0fff3cf2021-11-26T11:19:48ZHER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients1993-28201819-635710.1080/19932820.2021.1955462https://doaj.org/article/5ca28717abc94432969cecb6f0fff3cf2021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/19932820.2021.1955462https://doaj.org/toc/1993-2820https://doaj.org/toc/1819-6357Aim: Colorectal cancer (CRC) is one of the leading cancers in the world. Even though its mortality and pathophysiology are well documented in the US and the European countries, it is seldom studied in North African population. Recent studies have shown link of HER2 overexpression in oesophageal and gastric cancers. The aim of this study is to assess the HER2 protein and mRNA expression and its correlation with tumor pathogenesis in Libyan CRC patients. Methodology: A total of 17 FFPE tissue blocks were collected from patients with primary CRC. The HER2 protein expression was assessed by immunohistochemistry and the mRNA expression was assessed using qRT-PCR. Survival analysis of the role of HER2 overexpression on rectal adenocarcinoma was carried out on additional 165 patients. Results: From the CRC cohort, adenocarcinoma was found to be more frequent accounting for 88.2%, and 11.8% for mucinous adenocarcinomas. Almost 47% of the cases were positive for HER2 (score ≥ 2+) and about 50% adenocarcinoma cases with tumor grade II were positive for HER2. Moreover, 57.4% adenocarcinoma patients with grade-II tumor had undergone right hemicolectomy. Furthermore, significant correlation (p = 0.03) between the HER2 mRNA expression with the tumor grade was observed. In addition, poor overall all survival was observed with high HER2 expression in rectum adenocarcinoma. Conclusion: To our knowledge, this is the first study that HER2 overexpression correlates with more aggressive colorectal cancer in North African population. Our study shows that HER2 overexpression associates with right colon surgeries. Also, the correlation of mRNA and protein expression could warrant the implementation of a nationwide screening program for HER2 positivity in CRC patients. Taken together, stratifying patients according to HER2 expression can help in the diagnosis and prognosis of CRC patients from North African origin.Eman A. Abdul RazzaqThenmozhi VenkatachalamKhuloud BajboujMohamed RahmaniAmena MahdamiSurendra RawatNaziha MansuriHussein AlhashemiRifat Akram HamoudiRiyad BendardafTaylor & Francis Grouparticleher2crcihcMedicineRENLibyan Journal of Medicine, Vol 16, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	her2 crc ihc Medicine R
spellingShingle	her2 crc ihc Medicine R Eman A. Abdul Razzaq Thenmozhi Venkatachalam Khuloud Bajbouj Mohamed Rahmani Amena Mahdami Surendra Rawat Naziha Mansuri Hussein Alhashemi Rifat Akram Hamoudi Riyad Bendardaf HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
description	Aim: Colorectal cancer (CRC) is one of the leading cancers in the world. Even though its mortality and pathophysiology are well documented in the US and the European countries, it is seldom studied in North African population. Recent studies have shown link of HER2 overexpression in oesophageal and gastric cancers. The aim of this study is to assess the HER2 protein and mRNA expression and its correlation with tumor pathogenesis in Libyan CRC patients. Methodology: A total of 17 FFPE tissue blocks were collected from patients with primary CRC. The HER2 protein expression was assessed by immunohistochemistry and the mRNA expression was assessed using qRT-PCR. Survival analysis of the role of HER2 overexpression on rectal adenocarcinoma was carried out on additional 165 patients. Results: From the CRC cohort, adenocarcinoma was found to be more frequent accounting for 88.2%, and 11.8% for mucinous adenocarcinomas. Almost 47% of the cases were positive for HER2 (score ≥ 2+) and about 50% adenocarcinoma cases with tumor grade II were positive for HER2. Moreover, 57.4% adenocarcinoma patients with grade-II tumor had undergone right hemicolectomy. Furthermore, significant correlation (p = 0.03) between the HER2 mRNA expression with the tumor grade was observed. In addition, poor overall all survival was observed with high HER2 expression in rectum adenocarcinoma. Conclusion: To our knowledge, this is the first study that HER2 overexpression correlates with more aggressive colorectal cancer in North African population. Our study shows that HER2 overexpression associates with right colon surgeries. Also, the correlation of mRNA and protein expression could warrant the implementation of a nationwide screening program for HER2 positivity in CRC patients. Taken together, stratifying patients according to HER2 expression can help in the diagnosis and prognosis of CRC patients from North African origin.
format	article
author	Eman A. Abdul Razzaq Thenmozhi Venkatachalam Khuloud Bajbouj Mohamed Rahmani Amena Mahdami Surendra Rawat Naziha Mansuri Hussein Alhashemi Rifat Akram Hamoudi Riyad Bendardaf
author_facet	Eman A. Abdul Razzaq Thenmozhi Venkatachalam Khuloud Bajbouj Mohamed Rahmani Amena Mahdami Surendra Rawat Naziha Mansuri Hussein Alhashemi Rifat Akram Hamoudi Riyad Bendardaf
author_sort	Eman A. Abdul Razzaq
title	HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
title_short	HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
title_full	HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
title_fullStr	HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
title_full_unstemmed	HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
title_sort	her2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in north african patients
publisher	Taylor & Francis Group
publishDate	2021
url	https://doaj.org/article/5ca28717abc94432969cecb6f0fff3cf
work_keys_str_mv	AT emanaabdulrazzaq her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT thenmozhivenkatachalam her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT khuloudbajbouj her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT mohamedrahmani her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT amenamahdami her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT surendrarawat her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT nazihamansuri her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT husseinalhashemi her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT rifatakramhamoudi her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients AT riyadbendardaf her2overexpressionisaputativediagnosticandprognosticbiomarkerforlatestagecolorectalcancerinnorthafricanpatients
_version_	1718409472795213824

HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients

Ejemplares similares